SCHEMBL31023689

SCHEMBL31023689

O=CC1NCC12CC(=C(c1ccc3c(c1)COCO3)c1ccc3c(c1)COCO3)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31023806 0.77 SLC5A2 (0.30) —
SCHEMBL31023918 0.70 OPRD1 (0.36) —
SCHEMBL31023883 0.69 ALDH1A1 (0.32) —
SCHEMBL31023911 0.69 OPRM1 (0.38) —
SCHEMBL31023870 0.67 SRD5A2 (0.51) —
SCHEMBL31023706 0.66 OPRD1 (0.33) —
SCHEMBL13684320 0.65 ALDH1A1 (0.42) —
SCHEMBL3642753 0.65 TSHR (0.53) —
SCHEMBL3456941 0.65 KDM4E (0.53) —
SCHEMBL3641137 0.62 PRKCI (0.63) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665718-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF Apogee Pharmaceuticals, Inc. (CA) 2025-12-24 — — EP disclosed
WO-2024168426-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF APOGEE PHARMACEUTICALS, INC. (CA) 2024-08-22 — — WO disclosed
Send feedback